Photonpharma: Funding, Investors & Team (Oct 2026)
Photonpharma creates a platform for treating solid tumor cancers by utilizing the patient's own cells to activate their immune system to target and eliminate cancer cells. Their patented process deactivates the DNA/RNA of the patient's tumor cells while preserving the tumor-specific antigens for treatment.
Photonpharma has raised $4.7M across 3 funding rounds on record, the most recent a Seed of $2.5M announced in Aug 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Photonpharma Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Photonpharma Funding Rounds
Photonpharma raised $1.8M in a Seed announced in Mar 2022.
2.2 years later, an undisclosed round of $350k was announced in May 2024.
3 months later, a Seed of $2.5M was announced in Aug 2024.
Photonpharma Founders and Leadership Team
Contact details for the Photonpharma team: 1 of 2 have an email address on file.
Start 14-day free trial →Photonpharma Funding Compared to Other Biotechnology Startups
Photonpharma's latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Photonpharma in Biotechnology and Fort Collins
Companies Similar to Photonpharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Photonpharma Funding FAQs
What does Photonpharma do?
Photonpharma creates a platform for treating solid tumor cancers by utilizing the patient's own cells to activate their immune system to target and eliminate cancer cells. Their patented process deactivates the DNA/RNA of the patient's tumor cells while preserving the tumor-specific antigens for treatment.
How much funding has Photonpharma raised?
Photonpharma has raised $4.7M across 3 rounds on record. The most recent is a Seed of $2.5M announced in Aug 2024.
When did Photonpharma last raise funding?
Photonpharma's most recent funding round on record is a Seed of $2.5M, announced in Aug 2024.
Who founded Photonpharma?
FundedIQ lists Ray Goodrich (Founder) at Photonpharma.
Who is the CEO of Photonpharma?
Jon Weston is listed as CEO at Photonpharma.
Where is Photonpharma headquartered?
Photonpharma is based in Fort Collins, Colorado, United States.
How many employees does Photonpharma have?
Photonpharma is in the 1-10 employee band.
How does Photonpharma's funding compare to other Biotechnology startups?
Photonpharma's latest round of $2.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Photonpharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Photonpharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.